. Author manuscript; available in PMC: 2016 Aug 3.

Published in final edited form as: J Am Geriatr Soc. 2015 Aug 3;63(8):1512–1518. doi: 10.1111/jgs.13511

Table 3. Risk of Weight Loss With Cholinesterase Inhibitors, Stratified By Age, Comorbid Burden, And Initial Weight.

Subgroup	Number in Group	Hazard Ratio for Weight Loss (95% CI)	P-value for Difference in Hazard Ratio (Interaction Term)
Age
Age <=77 years	1,541	1.16 (0.93 – 1.43)	0.46
Age >77 years	1,836	1.28 (1.07 – 1.53)
Comorbid Burden
0-3 conditions	2,035	1.33 (1.11 – 1.59)	0.24
>3 conditions	1,342	1.13 (0.91 – 1.39)
Initial Weight
Weight <=170 pounds	1,592	1.26 (1.01 – 1.56)	0.94
Weight >170 pounds	1,785	1.25 (1.04 – 1.49)